|
Market Closed -
Nasdaq
00:00:00 17/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.470 USD | -1.76% |
|
+11.75% | +292.11% |
Evolution of the Average Target: AN2 Therapeutics, Inc.
Evolution of the Target Price: AN2 Therapeutics, Inc.
Changes in Analyst Recommendations: AN2 Therapeutics, Inc.
67.IdX5b8cas8cFdCWUP2yvMu3KmEEnqsFMbmJ6lIdEL2o.EL6jWIFu3IxpTE_nCliCR46D7zdW6K96Xjs5-_QhYghulI0WkUn58mRNcA~53636c99ff62468cb16adb69675279dc
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +101.34% | ||||
| +40.11% | ||||||
| +15.84% | ||||||
| +7.38% | ||||||
| +14.09% | ||||||
| +17.81% | ||||||
| +64.61% | ||||||
| +29.86% | ||||||
| +18.88% | ||||||
| +58.03% | ||||||
| Average | +36.79% | |||||
| Weighted average by Cap. | +27.32% |


Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.470USD
Average target price
9.000USD
Spread / Average Target
+101.34%
High Price Target
9.000USD
Spread / Highest target
+101.34%
Low Price Target
9.000USD
Spread / Lowest Target
+101.34%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ANTX Stock
- Consensus AN2 Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















